Medica SurB de CV's EBIT per Share for the
three
months ended in Dec. 2025 was $0.13.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.45.
During the past 12 months, the average EBIT per Share Growth Rate of Medica SurB de CV was 40.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 11.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 4.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 12.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medica SurB de CV's EBIT per Share or its related term are showing as below:
MSURF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -27.3 Med: 8.9 Max: 27
Current: 11.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Medica SurB de CV was 27.00% per year. The lowest was -27.30% per year. And the median was 8.90% per year.
MSURF's 3-Year EBIT Growth Rate is ranked worse than 50.28% of 529
companies
in the Healthcare Providers & Services industry
Industry Median: 11.8
vs MSURF: 11.70
Medica SurB de CV (OTCPK:MSURF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medica SurB de CV EBIT per Share Related Terms
Medica SurB de CV EBIT per Share Historical Data
* Premium members only.
The historical data trend for Medica SurB de CV's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medica SurB de CV (MSURF) has a EBIT per Share of $0.45 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medica SurB de CV and its competitors. According to the industry distribution chart, Medica SurB de CV ranks #266 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 50.3%.
Is Medica SurB de CV's EBIT per Share too high?
Medica SurB de CV's current EBIT per Share is $0.45. The Healthcare Providers & Services industry median EBIT per Share is 11.80. Medica SurB de CV's value of $0.45 is 96.2% below this industry median. Based on the distribution chart, Medica SurB de CV ranks #266 out of 529 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Medica SurB de CV has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's EBIT per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #266 out of 529 companies for EBIT per Share. This places Medica SurB de CV in the lower half of its industry. The industry median EBIT per Share is 11.80. Medica SurB de CV's value of $0.45 is 96.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medica SurB de CV's current EBIT per Share of $0.45 is 96.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medica SurB de CV and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medica SurB de CV's current EBIT per Share is $0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Medica SurB de CV (MSURF) has a current EBIT per Share of $0.45. The stock's GF Value™ is $0.53, compared to a current price of $0.67 — trading 27% above its estimated fair value. The current EBIT per Share is $0.45 and 96.2% below the Healthcare Providers & Services industry median of 11.80. Medica SurB de CV's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medica SurB de CV (MSURF), the current EBIT per Share is $0.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MSURF) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of $0.67 is trading 27% above its estimated GF Value™ of $0.53.
Key valuation signals for MSURF:
EBIT per Share: $0.45
GF Value™: $0.53 vs. price of $0.67 (27% above fair value)
Industry Position: 96.2% below the Healthcare Providers & Services median (#266 of 529)
No single metric tells the full story. See the MSURF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
84GF Score
Get the complete analysis for MSURF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSURF has been successfully added to your 
